An interventional study of Intermittent Pneumatic Compression (IPC) and Local Heat and Mechanical Vibration (Venom 2 Leg) in Basketball, Basketball Performance and Recovery, sponsored by Medipol University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by Medipol University · Not applicable, Interventional, and Treatment
The purpose of this study is to compare the effects of intermittent pneumatic compression, local heat, and mechanical vibration applications on recovery following high-intensity anaerobic exercise in elite female basketball players. Recovery levels of the athletes will be evaluated through blood lactate concentration, countermovement jump performance, perceived recovery status, and perceived muscle soreness. The study will compare the effects of different recovery application sequences on post-exercise recovery indicators.
High-intensity anaerobic exercise, especially in sports such as basketball involving repetitive sprints, jumps, and high-intensity efforts, can cause temporary fatigue and performance decrements following exercise. Accelerating post-exercise recovery is crucial for enabling athletes to become physically prepared for subsequent training sessions or competitions. Various physical recovery modalities are utilized to support recovery in athletes. Intermittent pneumatic compression is a method aimed at supporting circulation by applying controlled pressure to the extremities, contributing to the clearance of metabolic load accumulated after exercise. Local heat and mechanical vibration application aims to facilitate the recovery process by generating thermal and mechanical stimulation in the targeted region. However, further research is required to compare the effects of these two distinct modalities on recovery indicators following high-intensity anaerobic exercise. This study aims to examine the responses of elite female basketball players to different recovery applications following high-intensity anaerobic exercise. Changes during the recovery process will be monitored using biochemical, performance-based, and subjective evaluation measures. Thus, the potential effects of different physical recovery methods during post-exercise recovery will be evaluated comparatively. The findings obtained from this study are expected to contribute to the evaluation of recovery strategies applicable to elite female basketball players following high-intensity exercise, as well as to practices supporting athlete health and performance.
2,684 studies on the registry are indexed under Motor Activity; 1,217 are open to participants now.
This study's planned enrollment of 45 is below the median of 60 across 2,344 interventional studies indexed under Motor Activity.
Browse Motor Activity studies →Medipol University is the lead sponsor of 325 studies on the registry; 87 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria Female athletes aged 18-30 years. Being an active, licensed elite or professional female basketball player. Having played basketball regularly for at least 3 years. Being in the early follicular phase (days 2-5) of the menstrual cycle on the day of evaluation.
No history of severe lower extremity musculoskeletal injury or surgical operation in the last 6 months.
No regular use of medications that may affect physical performance or cardiometabolic responses.
Volunteering to participate in the study. Exclusion Criteria History of cardiovascular, neurological, or metabolic disease. Having experienced a lower extremity injury or undergone any surgical operation in the last 6 months.
Failure to comply with the pre-test restrictions (exercise, caffeine, alcohol, etc.) prior to the testing day.
Use of anticoagulant (blood thinner) medications or pregnancy. Presence of acute infection or delayed onset muscle soreness (DOMS) on the test day.
Occurrence of an injury during the study or emergence of any health problem that prevents continued participation.
Athletes in this group will undergo two consecutive recovery applications following the high-intensity anaerobic exercise protocol. First, intermittent pneumatic compression will be applied for 15 minutes, after which blood lactate concentration will be measured. This will be immediately followed by 15 minutes of local heat and mechanical vibration application. All procedures will be performed in accordance with the durations and standardized conditions specified in the study protocol. Recovery indicators will be evaluated at predetermined measurement time points before and after the applications.
Device: Intermittent Pneumatic Compression (IPC) · Device: Local Heat and Mechanical Vibration (Venom 2 Leg)
Athletes in this group will undergo two consecutive recovery applications following the high-intensity anaerobic exercise protocol. First, local heat and mechanical vibration will be applied for 15 minutes, after which blood lactate concentration will be measured. This will be immediately followed by 15 minutes of intermittent pneumatic compression application. All procedures will be performed in accordance with the durations and standardized conditions specified in the study protocol. Recovery indicators will be evaluated at predetermined measurement time points before and after the applications.
Device: Intermittent Pneumatic Compression (IPC) · Device: Local Heat and Mechanical Vibration (Venom 2 Leg)
Participants in this group will rest passively in a supine position for 30 minutes instead of receiving intervention applications. No recovery modality will be applied during the passive rest period.
Other: Passive Rest
Intermittent pneumatic compression will be applied following high-intensity anaerobic exercise using the Jobst compression device. The application will be performed on the lower extremities at a pressure of 80 mmHg for a total duration of 15 minutes. The standard intermittent pneumatic compression program of the device will be utilized during the procedure.
Local heat and mechanical vibration will be applied to both lower extremities following high-intensity anaerobic exercise using the Venom device. The application will last for a total duration of 15 minutes. Local heat will be administered at a medium level, and mechanical vibration will be applied using Mode 1 of the device.
Participants will rest in a supine position for 30 minutes.
Change in Post-Exercise Blood Lactate Concentration
Blood lactate measurement performed using a portable blood lactate analyzer from capillary blood samples obtained via fingertip puncture to evaluate the metabolic efficacy of recovery modalities following high-intensity anaerobic exercise (RAST). Measurement results are expressed in mmol/L.
Time frame: At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period.
Lower Extremity Neuromuscular Performance (CMJ)
A vertical jump test conducted to evaluate lower extremity neuromuscular performance. Participants are asked to perform a maximum vertical jump with their hands on their hips. The average jump height of three trials is recorded in centimeters (cm).
Time frame: At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period.
Perceived Recovery Status (PRS)
A single-item 0-10 point scale evaluating the subjective recovery level of athletes (0 = Very poorly recovered / Extremely tired, 10 = Completely recovered / Very well rested). Higher scores indicate better recovery status.
Time frame: At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period.
Perceived Muscle Soreness (VAS)
A 10-cm visual analog scale evaluating the level of perceived lower extremity muscle soreness following exercise. 0 cm indicates 'no pain' and 10 cm indicates 'unbearable pain.
Time frame: At baseline, 3 minutes post-RAST, immediately post-first intervention, and at the end of the second intervention or passive recovery period.
Plan to share: No — Individual participant data will not be shared to protect participant privacy and maintain confidentiality in accordance with institutional review board (IRB) and data protection guidelines.
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.